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Functional Implications of the IL-6 Signaling Pathway
in Keloid Pathogenesis
Mohammad Ghazizadeh1, Mamiko Tosa2, Hajime Shimizu1, Hiko Hyakusoku3 and Oichi Kawanami1
The molecular mechanism(s) behind keloid pathogenesis remains unclear. Previously by global gene expression
analysis of keloid fibroblasts (KFs), we implicated the IL-6 signaling pathway in keloid pathogenesis. Here, we
determine a functional role of IL-6 signaling in keloid scars. Primary cultures of KFs and surrounding
nonlesional fibroblasts (NFs) were subjected to induction or inhibition of IL-6 or its specific receptor IL-6
receptor alpha (IL-6Ra) and detection of their effects on extracellular matrix gene expression. The levels of
gp130 and several downstream targets in IL-6 signaling were also examined. IL-6 secretion was significantly
higher in KFs than NFs. Addition of IL-6 peptide to NFs culture or inhibition of IL-6 or its receptor IL-6Ra by their
corresponding antibodies in KFs culture revealed a dose-dependent increase or decrease in collagen type I
alpha 2 and fibronectin 1 mRNAs, respectively. Induction of IL-6 by IL-1b peptide and stimulation by IL-6 peptide
in NFs, or inhibition of IL-6 or IL-6Ra in KFs cultures demonstrated a dose-dependent increase or decease in
procollagen I synthesis, respectively. The mRNA and protein expressions of gp130 and several downstream
targets in IL-6 signaling (JAK1, STAT3, RAF1, and ELK1) were upregulated in KFs versus NFs. Our results indicate
that IL-6 signaling may play an integral role in keloid pathogenesis and provide clues for development of IL-6
receptor blocking strategies for therapy or prophylaxis of keloid scars.
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INTRODUCTION
Keloid scars are lesions of unknown etiology characterized
by fibroblastic proliferation and excessive collagen deposi-
tion. They develop as a result of an abnormal wound healing
that does not usually regress spontaneously, and they tend to
recur after excision. Many factors such as skin tension,
wound infection, racial difference, and genetic predisposition
have been implicated in the etiology of keloid lesions (Al-
Attar et al., 2006).
Treatment of keloid scars currently includes surgery alone
or in combination with corticosteroids or radiotherapy. In a
randomized trial for keloid therapy, a combination of surgery
and radiotherapy appeared to be more effective (12.5%
relapse) than that of surgery and corticosteroid injections
(33% relapse) at 12 months after treatment (Sclafani et al.,
1996). Recently, early postoperative electron beam irradia-
tion has proved to be a well-tolerated and effective method in
reducing the recurrence rate of keloid (Lo et al., 1990;
Mitsuhashi and Miyashita, 1995; Maarouf et al., 2002;
Thomas et al., 2003; Ogawa et al., 2003). However,
continuous efforts are needed to explore more effective and
less hazardous modes of therapy and prophylaxis for this
lesion. Understanding the mechanism(s) behind the develop-
ment of keloid scars is highly desirable in order to establish
such approaches.
Many studies have shown that cytokines, particularly IL-6,
play important roles in the pathogenesis of fibroproliferative
lesions that produce collagen. IL-6 produced by fibroblasts
has been linked to the pathogenesis of fibrosis associated
with rheumatoid arthritis, progressive scleroderma, and
pulmonary interstitial fibrosis (Tan et al., 1990; Feghali
et al., 1994; Gurram et al., 1994; Shahar et al., 1996).
Increased IL-6 gene expression and IL-6 production in keloid
patients has also been reported, suggesting an altered
increased autocrine regulation of IL-6 by keloid fibroblasts
(KFs) that signifies a central role for this cytokine in the
pathogenesis of keloid lesions (Xue et al., 2000). Moreover,
the formation of keloid scars are associated with accumula-
tion of extracellular matrix (ECM) components, mainly of
collagen (Friedman et al., 1993; Fujiwara et al., 2005) and
fibronectin (Kischer and Hendrix, 1983). KFs have also been
shown to exhibit as much as a 4-fold increase in the level of
fibronectin biosynthesis as compared to nonlesional fibro-
blasts (NFs) (Babu et al., 1989; Oliver et al., 1992).
In a previous study using cDNA microarray gene expres-
sion analysis and further corroborations, we identified a high
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expression of IL-6 mRNA and protein in KFs as compared to
nonlesional dermal fibroblasts (NFs) that suggested the
involvement of the IL-6 signal pathway in keloid pathogen-
esis (Tosa et al., 2005). In the present study, we attempted to
clarify the functional role of the IL-6 signaling pathway in
keloid pathogenesis through the effects of induction or
inhibition of IL-6 and its receptor IL-6 receptor alpha (IL-
6Ra) on ECM gene expression and collagen synthesis. We
also assessed the expression of gp130 (IL-6 signal transducer
protein or IL-6Rb) and several downstream targets in the IL-6
signaling pathway, including JAK1, STAT3, RAF1, and ELK1.
RESULTS
Growth rates of KFs and NFs
To characterize our cell culture system, we determined
differences in growth capabilities of KFs and NFs among the
cases. KFs demonstrated a significantly increased growth rate
from day 4 of culture as compared to NFs (Figure 1; Po0.05).
Comparison of the growth rates of KFs or NFs among the
cases showed no significant difference. We then examined
the effect of IL-6Ra inhibition by its corresponding antibody
on cell growth in KFs. The KF growth rate showed a marked
decline after the inhibition of IL-6Ra, approximating that of
the NF growth rate.
Detection of mRNA levels of IL-6, IL-6Ra, gp130, and
quantification of IL-6 secretion
To assess mRNA expression levels of IL-6, IL-6Ra, and gp130
(IL-6Rb), we performed semiquantitative reverse transcrip-
tion-PCR (RT-PCR) analyses. The mRNA levels of these
elements showed upregulation in cultured KF cells compared
to NF cells (Figure 2a). To determine whether increased IL-6
mRNA expression in KFs influenced IL-6 secretion, we
measured the amount of IL-6 in serum-free cultures of NF
and KF cases by an ELISA method. The mean IL-6 secretion
levels were 80728 pg/ml in NFs and 520740 pg/ml in KFs,
demonstrating a significant increase in KFs as compared to
NFs (Po0.01, Figure 2b).
Effect of addition of IL-6 peptide or inhibition of IL-6 or IL-6Ra
on ECM
To confirm that IL-6 expression affects ECM gene expression,
we examined whether addition of IL-6 peptide to NF or KF
culture promotes ECM gene expression or alternatively if in-
hibition of IL-6 or IL-6Ra expression in KF culture diminishes
ECM gene expression. We measured mRNA expressions of
two principal ECM molecules involved in keloid scarring
namely collagen type I alpha2 (COL1A2) and fibronectin 1
(FN1) in serum-free NF or KF cultures after addition of IL-6
peptide, or in serum-free KF cultures after inhibition of IL-6
with anti-IL-6 antibody or inhibition of IL-6Ra with anti-IL-
6Ra at various doses. The results showed that addition of IL-6
peptide to NF culture medium significantly and dose-
dependently enhanced COL1A2 and FN1 mRNA expressions
(Figure 3a; Po0.05), whereas inhibition of IL-6 by anti-IL-6
antibody or anti-IL-6Ra antibody in KF culture resulted in
dose-dependent decreases in COL1A2 and FN1 mRNA
expressions (Figure 3b and c; Po0.05). Addition of IL-6
peptide to KF culture showed slightly increased changes in
COL1A2 or FN1mRNA.
To provide evidence that IL-6 expression triggers increased
collagen synthesis, we examined the effects of IL-6 induction
or inhibition on collagen type I synthesis. We assessed the
direct effect of IL-6 peptide or indirect induction of IL-6 by IL-
1b peptide (a known IL-6 inducer) as inducers and effect of
anti-IL-6 or anti-IL-6Ra antibodies as inhibitors. We measured
procollagen I carboxyterminal propeptide (PICP) secreted by
the NFs or KFs that reflects the synthesis of type I collagen.
Addition of IL-1b peptide or IL-6 peptide to NF culture
medium, or anti-IL-6 or anti-IL-6Ra antibody to KF culture
medium, resulted in a significant dose-dependent increase or
decease in the synthesis of collagen type I, respectively
(Figure 4), whereas addition of IL-6 peptide to KF culture
medium showed slightly increased changes.
Detection of mRNA and protein expressions of downstream
targets in the IL-6 signaling pathway
To assess the mRNA expression levels of several downstream
targets in the IL-6 signaling pathway including JAK1, STAT3,
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Figure 1. Growth curves of cultured KFs and NFs demonstrated a marked
increase in KFs from day 4 of culture (Po0.05). The KFs growth rate was
declined to near that of NFs level after inhibition of IL-6Ra by its
corresponding antibody.
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Figure 2. (a) RT-PCR semiquantitative mRNA measurements of IL-6, IL-6Ra,
and gp130 in the IL-6 signal pathway in four cases each of cultured NFs
and KFs show increased levels in KFs compared to NFs. Glyceraldehyde
3-phosphate dehydrogenase serves as an internal control. Data represent
mean7SEM of the four cases in each group. (b) Quantification of IL-6
secretion by ELISA shows significant increases in cultured KFs compared
to NFs.
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RAF1, and ELK1, we performed semiquantitative RT-PCR
analyses. The mRNA levels of these elements showed
upregulation in KFs as compared to NFs (Figure 5).
To determine whether protein expressions of the down-
stream targets in IL-6 signaling were modulated similarly to
mRNA levels, Western blot analysis was performed. In-
creased expressions of both phosphorylated/activated and
total forms of JAK1, STAT3, RAF1, and ELK1 proteins were
observed in cultured KF cells compared to NF cells (Figure 6).
To confirm whether the ‘‘in vitro’’ increased mRNA and
protein levels of IL-6, IL-6Ra, gp130, and their downstream
targets JAK1, STAT3, RAF1, and ELK1 in KFs were in fact
reflected in the ‘‘in vivo’’ condition, we conducted immuno-
peroxidase localization of the protein products of these genes
in frozen or formalin-fixed, paraffin-embedded tissue sections
from 10 keloid lesions by immunohistochemistry. For
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Figure 3. Effect of IL-6 peptide or inhibition of IL-6 or IL-6Ra. ECM gene
expression by (a) addition of IL-6 peptide or (b) inhibition of IL-6 with anti-IL-6
antibody (c) or IL-6Ra with anti-IL6Ra antibody in serum-free NF or KF
cultures show significant dose-dependent increases or decreases in COL1A2
and FN1 mRNAs, respectively (Po0.05). Data represent mean7SEM of
triplicate measurements.
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Figure 4. Effect of IL-6 induction or inhibition on collagen synthesis.
Determination of collagen synthesis by measuring PICPs after induction of
IL-6 by IL-1b peptide, and stimulation by IL-6 peptide in cultured NFs, or
inhibition of IL-6 or IL-6Ra in cultured KFs demonstrate a dose-dependent
increase or decease in PICP respectively (Po0.05 for doses 420 vs 0).
Data represent mean7SEM of triplicate measurements in each group.
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Figure 5. mRNA and protein expressions of the downstream targets. RT-PCR
semiquantitative mRNA measurements of several downstream targets (JAK1,
286 bp; STAT3, 378 bp; RAF1, 667 bp, and ELK1, 494 bp) in the IL-6 signal
pathway in four cases each of cultured NFs and KFs show increased levels in
KFs compared to NFs. Glyceraldehyde 3-phosphate dehydrogenase (226 bp)
serves as an internal control. Data represent mean7SEM of the four cases
in each group.
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Figure 6. Representative Western blot analysis of three randomly selected
cases of cultured KFs and NFs. Equal amounts of total cell lysates from KF
and NF cultured cells were size fractionated on SDS-polyacrylamide gels,
blotted onto polyvinylidene difluoride membranes and Western blot was
performed using antibodies to total or phosphorylated forms for each element.
Increased protein expression is observed for phosphorylated/activated and
total forms of JAK1, STAT3, RAF1, and ELK1 in KFs compared to NFs.
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formalin-fixed tissue sections, conventional antigen retrieval
using heat was necessary in order to detect antigens.
However, this method did not work in the case of RAF1
localization. We applied a universal antigen retrieval method
recently developed by us (Namimatsu et al., 2005) and were
able to detect RAF1 in formalin-fixed, paraffin-embedded
tissue sections. In general, KFs frequently showed a positive
reaction as compared to subepidermal NFs adjacent to the
epidermis (Figure 7). Overall, KFs showed a moderate to
strong expression for IL-6 in eight, IL-6Ra in eight, gp130 in
six, JAK1 in six, STAT3 in seven, RAF1 in six, and ELK1 in
eight cases. The remaining cases mostly showed weak
expressions. The enhanced mRNA and protein expressions
of the IL-6 signaling elements in KF cultures were thus
frequently represented at the visual localization level in
keloid tissues.
DISCUSSION
Keloid scaring develops as a result of abnormal wound
healing that grows beyond the wound margins and exhibits
inflammation, fibroblastic cell proliferation, and accumula-
tion of excessive collagen deposits. In this study, we establish
the functional role of the IL-6 signaling pathway in this lesion.
Our data confirm that IL-6 secretion is significantly increased
in KF cultures compared to NF cultures, as has been shown
previously (Xue et al., 2000). Addition of IL-6 peptide to NF
culture or inhibition of IL-6 or its receptor IL-6Ra by their
corresponding antibodies in KF culture significantly and
dose-dependently enhances or reduces COL1A2 and FN1
mRNA expressions, respectively. Induction of IL-6 by IL-1b
and stimulation by IL-6 peptide in NF cultures, or inhibition
of IL-6 or IL-6Ra by their corresponding antibodies in KF
cultures render a dose-dependent increase or decrease in the
synthesis of collagen type I, respectively. Our finding that IL-6
induces collagen synthesis in fibroblasts is in agreement with
the previous studies (Duncan and Berman, 1991). We also
show that several downstream targets in the IL-6 signaling
pathway are upregulated at transcriptional and translational
levels. Overexpression and phosphorylation/activation of
these target elements in KFs as shown here may play a
pivotal role in the proliferation and excessive collagen
deposition by fibroblasts leading to abnormal scar formation.
Previous studies have shown that cytokines can alter
fibroblast proliferation, synthesis of ECM components, as well
as other functions that may regulate pathogenesis of
autoimmune fibrotic diseases and keloid scar as well (Elias
et al., 1990; Ferrarini et al., 1990; McCauley et al., 1992).
IFN-g regulates IL-6 secretion from fibroblasts by stimulating
the expression of major histocompatibility complex class II
and CD40 (Mourad et al., 1992; Yellin et al., 1995). IFN-g has
also been reported to increase protein production, inhibit
DNA synthesis, and increase IL-6 expression in normal
dermal fibroblasts (Maruyama et al., 1995). The production of
IFN-a, IFN-g, and tumor necrosis factor-b are markedly
depressed in keloid patients compared to normal controls
(McCauley et al., 1992). However, IL-1 and IL-2 production is
not significantly different between the two groups. In
contrast, keloid patients produce greater amounts of IL-6,
IFN-b, and tumor necrosis factor-a.
Increased expression of IL-6 in normal rat skin induces
epidermal proliferation and inflammation (Sawamura et al.,
1998), and addition of IL-6 to human synovial fibroblast cells
induces fibroblast proliferation (Mihara et al., 1995). We find
that the addition of anti-IL-6Ra antibody to KF cultures
inhibits cell growth. Furthermore, mRNA and secreted
protein levels of pro-matrix metalloproteinase-1 and matrix
metalloproteinase-3 are elevated in the supernatants from
normal skin fibroblasts after treatment with IL-6, whereas no
changes are observed in hypertrophic scar fibroblasts treated
with IL-6 (Dasu et al., 2004). This suggested that suppression
of matrix metalloproteinases may play a role in the excessive
accumulation of collagen formed in hypertrophic scars.
Other studies found that IL-6 could markedly increase ECM
elements such as matrix metalloproteinase-1 and tissue
inhibitor of metalloproteinase-1 expression at mRNA level
and pro-matrix metalloproteinase-1 at the protein level (Dasu
et al., 2003) as well as collagen synthesis (Duncan and
Berman, 1991; Friedman et al., 1993). In agreement with
these results, we also found that IL-6 peptide induces
collagen synthesis in human fibroblast cultures in vitro.
Collectively, these findings suggest that altered levels of
immunoregulatory cytokines, particularly IL-6 and its recep-
tor IL-6Ra, may play a significant role in the proliferation of
fibroblasts and net increase in collagen synthesis, which
characterizes keloid formation.
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Figure 7. Immunoperoxidase stainings of keloid tissues. Hematoxylin and
eosin-stained section shows fibroblast proliferation and abundant broad
bundles of collagen deposits. KFs frequently showed moderate to strong
expressions for IL-6, IL-6Ra, gp130, JAK1, STAT3, RAF1, and ELK1. Inset
represents immunostaining in NFs from the section. Bar¼ 200mm.
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In skin wound healing, IL-6 mRNA and protein are
detected in neutrophils, macrophages, and fibroblasts in the
wound sites (Sato and Ohshima, 2000). In streptozotocin-
induced diabetic mice, IL-6 levels in wound fluids correlate
with wound-healing rates (Fahey et al., 1991) and the
exogenous IL-6 administration reverses impaired wound
healing in immunosuppressed mice by glucocorticoid (Gal-
lucci et al., 2001), suggesting the potential involvement of
IL-6 in skin wound healing. Furthermore, IL-6 is shown to
induce the proliferation of fibroblasts (Mihara et al., 1995)
and indirectly induce keratinocyte migration possibly through
a soluble fibroblast-derived factor and rapid and sustained
phosphorylation of STAT3 protein (Gallucci et al., 2004) thus
can efficiently influence wound healing.
In a study by Gallucci et al. (2000), transgenic IL-6-
deficient mice exhibit impairment in skin wound healing in
parallel with a reduced activation of a transcription factor,
activated protein-1, at the wound site. Lin et al. (2003) have
observed a reduction in leukocyte infiltration, re-epitheliali-
zation, angiogenesis, and collagen deposition at wound sites
in transgenic IL-6-deficient mice compared with wild-type
mice. Finally, the administration of a neutralizing anti-IL-6
monoclonal antibody significantly delays wound closure in
wild-type mice. A recent study also reports modulation of
a-smooth muscle actin expression by recombinant mouse
IL-6 peptide in the dermal fibroblasts from transgenic IL-6-
deficient mice (Gallucci et al., 2006). In these fibroblasts,
recombinant mouse IL-6 peptide induces a-smooth muscle
actin, apparently transcriptionally regulated depending on
JAK1 kinase, thus implicating an important role for IL-6 in
pathologies associated with myofibroblast dysregulation such
as chronic wounds or contractures from burn injury. Further
evidence demonstrates that IL-6 can induce collagen
production and/or procollagen gene expression in several
types of cells, including dermal fibroblasts (Duncan and
Berman, 1991). In fetal wound healing that is characterized
by minimal inflammation and scarless repair, less IL-6 protein
and mRNA are produced by fetal fibroblasts than adult
fibroblasts, and IL-6 administration to fetal wounds results in
scar formation (Liechty et al., 2000). Thus, IL-6 deficiency
can directly reduce collagen deposition in wound sites. These
observations suggest that IL-6 has pivotal roles in wound
healing, perhaps by regulating leukocyte infiltration and
collagen deposition.
Another requirement of wound healing is the formation of
granulation tissue that is associated with neovascularization.
IL-6 is implicated in angiogenesis by in vitro evidence of
inducing proliferation of brain microvascular endothelial
cells and formation of tube-like structures (Fee et al., 2000)
and also by induction of vascular endothelial growth factor
production (Cohen et al., 1996). Additionally, vascular
endothelial growth factor gene expression is reduced at the
wound site of IL-6-deficient mice compared to wild-type
mice (Lin et al., 2003). These observations suggest that IL-6
may also induce angiogenesis by induction of vascular
endothelial growth factor production in skin wound healing.
In our study, the key elements of the IL-6 signaling
pathway, IL-6 and its receptor IL-6Ra and gp130 (IL-6Rb)
together with a number of downstream targets including
JAK1, STAT3, RAF1, and ELK1 are upregulated at mRNA and
protein levels in KFs compared to NFs. The upregulation of
the IL-6 gene appears to have conferred a positive effect
toward keloid formation. IL-6 can initiate transduction
through the gp130 signal transducer subunit leading to the
rapid activation of numerous signaling pathways including
that of JAK/STAT3 and extracellular signal-regulated kinase/
mitogen-activated protein kinase. The mitogen-activated
protein kinase pathway can activate several transcription
factors including ELK1 and NFs-IL-6 (CEBPB), which may
affect fibroblastic cell proliferation and matrix synthesis. In
addition, RAF kinases transmit signals that induce cell
proliferation, differentiation, and survival. The RAF1 isoform
acts as the upstream kinase linking RAS activation to the
mitogen-activated protein kinase kinase/extracellular signal-
regulated kinase module. Recently, the requirement of RAF1
for normal wound healing in vivo and for the migration of
kerantinocytes and fibroblasts in vitro has been shown
(Ehrenreiter et al., 2005).
In this study, we used low-passage primary fibroblast
cultures to obtain results near to the in vivo tissue condition.
Primary fibroblast cultures are more homogenous than fresh
tissue that contains various cell types leading to complicated
results. It should be noted that functional competency can be
vastly different between the cells in long-term established
cultures in vitro and whole tissue in vivo. Furthermore, the
cell–cell, cell–ECM, and cell–host interactions may signifi-
cantly affect functional behavior in vivo relative to the in vitro
conditions of established cell lines. Nevertheless, our study
strongly documented the involvement of inflammatory
cytokine IL-6 in the pathogenesis of keloid lesion.
In conclusion, our functional analyses of KFs revealed
that the IL-6 signaling pathway holds a major role. It is likely
that targeted inhibition of the IL-6 receptors may be feasi-
ble for inhibiting keloid formation, thus offering novel
possibilities for therapeutic intervention or prophylaxis of
this lesion.
MATERIALS AND METHODS
Tissues and cell culture
Tissue samples from lesional areas of keloid along with associated
nonlesional skin margins were obtained from four patients with
untreated primary keloid scar during surgery. Informed consents had
been obtained from all patients. The study was conducted with the
institutional approval of experiments and adherence to the Declara-
tion of Helsinki Principles. The patients were all females and ranged
in age from 23 to 28 years. The location of keloid lesions was on the
chest area and they had developed after complete resolution of acne
vulgaris. No patient was on any form of therapy. Hematoxylin and
eosin-stained sections from the tissues were histologically examined
to confirm the nature of keloid and associated nonlesional skin.
Primary fibroblast cultures were established as previously
described (Arakawa et al., 1990). KFs and NFs were cultured in
DMEM, supplemented with 10% fetal calf serum, penicillin (100 IU/
ml), streptomycin (100 mg/ml), and amphotericin B (0.25 mg/ml) at
371C in a humidified 5% CO2 incubator. The cells were harvested by
trypsinization (0.25%) and secondary cultures were maintained in
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the same medium until reaching 80% confluence. Only low-passage
cultures (passages 3–4) were utilized in this study.
Growth rates of KFs and NFs
KF or NF cells (1 105) were cultured in six-well culture plates using
DMEM supplemented with 5% fetal bovine serum. At days 2, 4, 6,
and 8 after the culture, the cells were harvested using trypsin/EDTA,
washed in phosphate-buffered saline fixed in absolute ethanol and
kept in 70% ethanol. The cells were stained with propidium iodide,
and DNA fluorescence was measured using a flow cytometer
according to a method described previously (Nicoletti et al., 1991).
The percentages of living cells were determined at each time point
and the corresponding growth curves were constructed. All
experiments were performed in triplicate and mean7SEM values
were determined.
RNA preparation and semiquantitative RT-PCR
Culture flasks (75 cm2) containing nearly 80% confluent KFs and NFs
were prepared and the cells were harvested and subjected to RNA
isolation using the RNeasy Midi Kit (Qiagen, Hilden, Germany)
based on the manufacturer’s instructions. The RNA was treated with
DNase and precipitated using 95% ethanol before cDNA synthesis.
Isolated RNA was electrophoresed through 1.0% agarose-formalde-
hyde gels to verify the quality of the RNA, and RNA concentrations
were determined by UV spectrophotometry.
From each sample, 1.5 mg of total RNA was reverse-transcribed
using the gene-specific primers. The number of PCR cycles was
optimized in each case to ensure that product intensity fell within the
linear phase of amplification. The primer pair sequences were:
COL1A2 forward 50-CAG CCC CGT GGC CAC GTC CC-30
(nucleotide 149–168), reverse 50-CCA CAG GCC CTC CTG GTC
CA-30 (nucleotides 644–663); FN1 forward 50-GCG CCG GCT GTG
CTG CAC AGG-30 (nucleotides 5–25), reverse 50-GCC TGG GGA
CAG CGG TGC CC-30 (nucleotides 313–332); IL-6 forward 50-ACA
GCC ACT CAC CTC TTC AG-30 (nucleotides 194–213), reverse
50-CCA TCT TTT TCA GCC ATC TTT-30 (nucleotides 341–361) and
IL-6Ra forward 50-CTC AGT GTC ACC TGG CAA GA-30 (nucleotides
699–718), reverse 50-TGT CGC ATT TGC AGA ATC TC-30
(nucleotides 1036–1055). In addition, mRNA expressions of four
downstream targets in the IL-6 signal pathway, gp130 forward
50-TGC TGA TTG CAA AGC AAA AC-30 (nucleotides 507–526),
reverse 50-TTT CCA TTG GCT TCA AAA GG-30 (nucleotides
1066–1085), JAK1 forward 50-GTC CTT CTC CTG CAA CAA
ATG-30 (nucleotides 137–157), reverse 50-TGG TAA TGC AGT
TGT GAT GGT-30 (nucleotides 402–422), STAT3 forward 50-CTG
AGC TGG CAG TTC TCC TC-30 (nucleotides 1522–1541),
reverse 50-CTG GGT CTT ACC GCT GAT GT-30 (nucleotides
1880–1899), RAF1 forward 50-TCA ATG TGC GAA ATG GAA
TG-30 (nucleotides 209–228), reverse 50-GCT GAA GGT GAG GCT
GAT TC-30 (nucleotides 875–894), and ELK1 forward 50-GAA AGT
AGA AGG GCC CAA GG-30 (nucleotides 744–763), reverse 50-CCA
CGC TGA TAG AAG GGA TG-30 (nucleotides 1218–1237)
were examined. The expected PCR products were 515,
328,168, 357, 579, 286, 378, 667, and 494 bp for COL1A2,
FN1, IL-6, IL-6Ra, gp130, JAK1, STAT3, RAF1, and ELK1 genes,
respectively. Glyceraldehyde 3-phosphate dehydrogenase was
used as the internal control. The PCR bands were quantitated
by densitometry using Quantity One Software (Bio-Rad Labs.,
Hercules, CA) and expressed relative to glyceraldehyde 3-phosphate
dehydrogenase. The results were recorded as mean7SEM of
triplicate experiments.
ELISA of IL-6
One hundred microliters of a 7 104 KF or NF cells/ml suspension in
DMEM with 5% fetal bovine serum was seeded in 96-well plates in
triplicate for 3 days. Then, 100 ml of serum-free medium was added
for 12 hours. The supernatants were collected for detection of IL-6
using the human IL-6 immunoassay kit according to the manufac-
turer’s instructions (R&D Systems, Minneapolis, MN). Briefly, the
samples were incubated in plates coated with anti-IL-6 antibody for
2 hours at room temperature. The plates were then incubated with
the antibody against IL-6 conjugated to horseradish peroxidase for
2 hours at room temperature. Finally, substrate solution was added to
each plate for chromogenic reaction. All plates were read using an
ELISA reader set at 450 nm. Each assay was performed in triplicate
and the results were recorded as means7SEM.
ECM gene expression by addition of IL-6 or inhibition of IL-6 or
IL-6Ra
KFs or NFs were seeded on 24-well plates at 7 104 cells/well. After
reaching subconfluence, the cultures were serum deprived for
24 hours. IL-6 peptide (Sigma-Aldrich, St Louis, MO) was added to
NF cultures at doses 0, 10, 20, and 40 ng/ml of serum-free medium
and the cultures were incubated for an additional 12 hours, after
which the cells were collected. Monoclonal anti-IL-6 (R&D Systems
Inc.) or rabbit anti-IL6Ra antibody (Santa Cruz Biotechnology Inc.,
Santa Cruz, LA) was added to KF cultures at doses between 0, 10, 20,
and 40 mg/ml of serum-free medium and the cultures were incubated
for an additional 12 hours, then the cells were collected. The
collected NF and KF cells were examined for COL1A2 and FN1
mRNA expressions by a semiquantitative RT-PCR. The PCR bands
were quantitated by densitometry using Quantity One Software
(Bio-Rad) and expressed relative to glyceraldehyde 3-phosphate
dehydrogenase. The results were recorded as mean7SEM of
triplicate experiments.
Quantification of PICP after induction of IL-6 or inhibition
of IL-6 or IL-6Ra
Collagen type I derives from a larger protein termed procollagen type
I, which has propeptide extensions at both ends of the molecule.
Before the collagen molecules are assembled into fibers, the
propeptides are removed by specific enzymes. The sequence
removed from the carboxyterminal end namely PICP is secreted by
the cells and its measurement reflects the synthesis of type I collagen.
NFs or KFs were seeded on 24-well plates at 7 104 cells/well. After
reaching subconfluence, the cultures were serum deprived for
24 hours. IL-1b (Sigma-Aldrich), a known inducer of IL-6, was added
to NF cultures at doses 0, 10, 20, and 40 ng/ml and anti-IL-6 or anti-
IL-6Ra monoclonal antibody was added to KF cultures at doses 0,
10, 20, and 40 mg/ml serum-free medium respectively. In another
series of experiments, IL-6 peptide at doses 0, 10, 20, and 40 ng/ml
was added to NF and KF cultures. The cultures were incubated for an
additional 24 hours. The medium in each well was collected and
processed for PICP radioimmunoassay using rabbit anti-human PICP
antibody (Orion Diagnostica, Espoo, Finland). The results were
recorded as mean7SEM of triplicate experiments.
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Western blot analysis
Proteins were extracted from the subconfluent primary cultures of
three representative cases each of KFs and NFs. Equal amounts of
protein (20 mg/lane) were size fractionated on SDS-polyacrylamide
gels, blotted onto an Immobilon polyvinylidene difluoride mem-
branes (Bio-Rad Laboratories, Hercules, CA) in transfer buffer
containing 192 mM glycine, 25 mM Tris-HCl, pH 8.3, 20% v/v
methanol, and 0.02% SDS), and incubated with blocking buffer (5%
nonfat dry milk, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1%
Tween-20) overnight at 41C. Duplicate series of membranes were
prepared and incubated overnight at room temperature with 1:500
dilutions of primary antibodies against each total or phosphorylated
form of proteins. Primary antibodies used were rabbit anti-JAK1,
STAT3, RAF1, and ELK1 (Santa Cruz), rabbit anti-phosphorylated
forms of JAK1 (Tyr1022/1023) and STAT3 (Tyr705) (Cell Signaling
Technology Inc., Beverly, MA) and goat anti-phosphorylated RAF1
(Ser338) and mouse anti-phosphorylated ELK1 (Ser383) antibodies
(Santa Cruz). After washes with Tris buffered saline with 0.1% Tween
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Tween-20) buffer and
treatment with corresponding alkaline phosphatase-conjugated
secondary antibodies, the reactions were developed with the
ProtoBlor NBT and BICP Color Development System (Promega,
Madison, WI).
Immunohistochemistry
Immunoperoxidase staining for IL-6, IL-6Ra, gp130, JAK1, STAT3,
RAF1, and ELK1 was performed on frozen or deparaffinized paraffin
sections from 10 randomly selected keloid lesions using a
streptavidin–biotin peroxidase complex method (Ghazizadeh et al.,
2005). The primary antibodies were applied after appropriate
antigen retrieval methods recommended by the manufacturers. We
also applied a universal antigen retrieval method recently developed
at our institute (Namimatsu et al., 2005). Briefly, the endogenous
peroxidase was blocked with 0.3% hydrogen peroxide in distilled
water for 30 minutes. After washes in phosphate-buffered saline,
nonspecific binding sites in tissues were blocked with 10% normal
serum and the sections were incubated overnight with 1:50 or 1:100
dilution of a primary antibody. After washes in phosphate-buffered
saline, appropriate biotinylated secondary antibodies were applied
followed by washes in phosphate-buffered saline and detection
using a streptavidin–biotin–peroxidase staining kit (Histofine, Nichir-
ei, Japan). Diaminobenzidine was used as chromogen. The sections
were counterstained with hematoxylin. Negative controls included
omission of the primary antibody and its substitution with
nonimmune sera. The staining results were semiquantitated as
negative, weak, moderate, or strong, if 0–5, o25, 25–50, and
450%, respectively, of the fibroblastic cytoplasm or nuclei showed
distinct brown staining.
Statistical analysis
Statistical analyses were performed using the Student’s t-test
for paired data to identify differences within groups before and after
a given treatment and Bonferroni’s test to identify differences
between groups. A P-value of less than 0.05 was considered
as significant.
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